PhyloMed Corporation

Founded in 1983, the PhyloMed Corporation is a bio-pharmaceutical company based in Florida. The Company has a broad base of interests encompassing every form of disease. Staffed by scientists from diverse disciplines, a solid foundation has been laid on which exciting therapeutics will be developed. Such diverse talents create a single entity with a single focus - to develop novel approaches to the treatment of disease. The Company’s technology has been in development for over 10 years. During this period extensive research and development has been undertaken in its’ areas of interest. The organization now seeks to enter into clinical studies and is ready to submit to licensing authorities. Rooted firmly in the treatment of viral and neurological disorders the company’s first drug will be for the treatment of progressive multiple sclerosis, a disease of unknown etiology. Our lead drug “Immunokine”

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Infectious Diseases
- Neurology

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: